Scientific Writer II jobs in United States
cer-icon
Apply on Employer Site
company-logo

Inotiv · 15 hours ago

Scientific Writer II

Inotiv is a growing contemporary drug discovery and development company, and they are seeking a Scientific Writer II to partner with study directors and scientific staff to produce high-quality documentation from pre-clinical study data. The role involves ensuring accuracy and consistency in reports, performing statistical analysis, and maintaining templates to enhance workflow efficiency.

BiopharmaLife ScienceMedical DevicePharmaceutical
check
H1B Sponsor Likelynote

Responsibilities

Partner with scientific staff to produce accurate and concise reports and data packages
Setup spreadsheets or other documentation as directed by scientific staff to allow for accurate and efficient data entry
Create, edit, and format tables and figures from applicable software programs
Analyze and interpret data across a range of therapeutic areas
Review reports and other documents for clarity and conformance with applicable templates
Work with other departments, groups, or teams as necessary to create and issue reports, amendments, and other required deliverables
Convert deliverables to PDF and format them in compliance with applicable FDA guidelines and Inotiv style guides and templates
Sense of urgency to ensure that internal and external deadlines are met
Detail-oriented and capable of producing consistent, error-free, quality deliverables
Maintain thorough knowledge of facility SOPs, policies, study protocols, etc
Excellent organizational, communication, time management, and interpersonal skills in a cross-functional team
General understanding of relevant regulations (e.g., GLP and GCP)
Perform other duties as assigned

Qualification

Scientific writingStatistical analysisGraphPad PrismR programmingMicrosoft OfficeAdobe AcrobatVivo modelsInterpersonal skillsOrganizational skillsTime management

Required

Master's degree or higher in a related discipline (Physiology, Pharmacology, Immunology, etc)
At least 2 years of experience in pre-clinical in vivo models of disease
Understanding of in vivo models of multi-system rodent physiology, immunology, neuroscience, histopathology, and in vitro analyses of pathobiology and disease biomarkers (molecular pharmacology and toxicology)
Ability to work independently as well as collaboratively with others across different company sites to ensure document accuracy, consistency, and professional appearance
Proficient in Microsoft Office, Adobe Acrobat, GraphPad Prism, and R
Follow all SOPs and other applicable laboratory or company policies and procedures
Interact with clients, other employees, and the community in a professional manner
Ability to adhere to all company policies, safety regulations and procedures
Maintain confidential information
Demonstrate Inotiv Core Values and adhere to Code of Conduct
Detail-oriented and capable of producing consistent, error-free, quality deliverables
Excellent organizational, communication, time management, and interpersonal skills in a cross-functional team
General understanding of relevant regulations (e.g., GLP and GCP)

Preferred

Past pre-clinical, scientific, and/or technical writing experience preferred

Benefits

Health and dental coverage
Short- and long-term disability
Paid time off
Paid parental leave
401K
And more

Company

Inotiv

twittertwittertwitter
company-logo
Inotiv provides biopharmaceutical analytical, reproductive toxicology, medical device testing, DMPK, consulting and pathological services.

H1B Sponsorship

Inotiv has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (1)
2024 (1)
2023 (2)
2022 (1)

Funding

Current Stage
Public Company
Total Funding
$27.64M
Key Investors
Indiana Economic Development Corporation
2024-12-18Post Ipo Equity· $27.6M
2022-06-20Grant· $0.04M
1997-11-28IPO

Leadership Team

leader-logo
Greg Beattie
Chief Operating Officer
linkedin
Company data provided by crunchbase